Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
Authors
Keywords
Heart failure, SGLT2 inhibitors, Mechanism, Mode of action, NT-proBNP, Daily activity level, Cardiac function, Metabolic endpoints, Renal endpoints, Quality of life
Journal
Trials
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-21
DOI
10.1186/s13063-019-3474-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
- (2018) Karin Rådholm et al. CIRCULATION
- SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
- (2018) Subodh Verma et al. DIABETOLOGIA
- Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs
- (2018) Mikhail Kosiborod et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes
- (2018) Thomas A. Zelniker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multidimensional contractile reserve predicts adverse outcome in patients with severe systolic heart failure: a 4-year follow-up study
- (2017) Ioannis A. Paraskevaidis et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure
- (2017) Milton Packer et al. JAMA Cardiology
- Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
- (2016) Ele Ferrannini et al. DIABETES
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial
- (2016) David Fitchett et al. EUROPEAN HEART JOURNAL
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial
- (2016) Anders Jorsal et al. EUROPEAN JOURNAL OF HEART FAILURE
- Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
- (2015) Margaret M. Redfield et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Value of Estimated Plasma Volume in Heart Failure
- (2015) Kévin Duarte et al. JACC-Heart Failure
- The Relative Impacts of Disease on Health Status and Capability Wellbeing: A Multi-Country Study
- (2015) Paul Mark Mitchell et al. PLoS One
- Characteristics and Outcomes of Patients With Heart Failure and Discordant Findings by Right-Sided Heart Catheterization and Cardiopulmonary Exercise Testing
- (2014) Chetan B. Patel et al. AMERICAN JOURNAL OF CARDIOLOGY
- Relationships Between Biomarkers and Left Ventricular Filling Pressures at Rest and During Exercise in Patients After Myocardial Infarction
- (2014) Mads J. Andersen et al. JOURNAL OF CARDIAC FAILURE
- A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study)
- (2014) Anders Jorsal et al. BMJ Open
- Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction in Patients With Preserved Ejection Fraction
- (2013) Mads J. Andersen et al. CIRCULATION
- Incremental Prognostic Value of Assessing Left Ventricular Myocardial Mechanics in Patients With Chronic Systolic Heart Failure
- (2012) Hirohiko Motoki et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure
- (2010) Stephan von Haehling et al. EUROPEAN JOURNAL OF HEART FAILURE
- Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis
- (2010) Michael Egstrup et al. EUROPEAN JOURNAL OF HEART FAILURE
- Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure
- (2009) Takayoshi Tsutamoto et al. AMERICAN HEART JOURNAL
- Albuminuria in chronic heart failure: prevalence and prognostic importance
- (2009) Colette E Jackson et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now